(Q35692156)

9 August 2017

0 references

A regimen of taxol, Ifosfamide, and platinum for recurrent advanced squamous cell cancer of the anal canal (English)

1 reference

9 August 2017

1 reference

1 reference

Diana V Golub

1

1 reference

9 August 2017

A Cahid Civelek

series ordinal

2

1 reference

9 August 2017

Vivek R Sharma

series ordinal

3

1 reference

9 August 2017

publication date

15 June 2011

1 reference

Chemotherapy Research and Practice

9 August 2017

published in

1 reference

9 August 2017

volume

2011

1 reference

9 August 2017

page(s)

163736

1 reference

Creative Commons Attribution 3.0 Unported

9 August 2017

copyright license

start time

15 June 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265251

Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265251

Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265251

Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265251

Phase II study of mitomycin-C, adriamycin, cisplatin (MAP) and Bleomycin-CCNU in patients with advanced cancer of the anal canal: An eastern cooperative oncology group study E7282.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265251

Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265251

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265251

Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265251

The National Cancer Data Base report on carcinoma of the anus

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265251

Combined therapy for cancer of the anal canal: a preliminary report. 1974.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265251

Carcinoma of the anal canal, a clinical and pathologic study of 188 cases

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265251

Cetuximab-based treatment of metastatic anal cancer: correlation of response with KRAS mutational status.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265251

Evidence of clinical activity for cetuximab combined with irinotecan in a patient with refractory anal canal squamous-cell carcinoma: report of a case.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265251

Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265251

Response of metastatic epidermoid anal cancer to single agent irinotecan: a case report

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265251

Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy

25 September 2018

1 reference

12 December 2020

Response of metastatic anal carcinoma to single agent carboplatin

1 reference

12 December 2020

Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous-cell cervical cancer

1 reference

12 December 2020

Cisplatin and 5-fluorouracil as salvage therapy for recurrent metastatic squamous cell carcinoma of the anal canal

1 reference

12 December 2020

Squamous cell carcinoma of the anus at one hospital from 1948 to 1984

1 reference

12 December 2020

Metastatic cloacogenic carcinoma of the anus: sequential responses to adriamycin and cis-dichlorodiammineplatinum(II)

1 reference

12 December 2020

Identifiers

DOI

10.1155/2011/163736

1 reference

9 August 2017

1 reference

9 August 2017

1 reference